The latest closing stock price for Viking Therapeutics as of February 21, 2025 is 34.07.
An investor who bought $1,000 worth of Viking Therapeutics stock at the IPO in 2015 would have $2,802 today, roughly 3 times their original investment - a 14.29% compound annual growth rate over 10 years.
The all-time high Viking Therapeutics stock closing price was 94.50 on February 28, 2024.
The Viking Therapeutics 52-week high stock price is 99.41, which is 191.8% above the current share price.
The Viking Therapeutics 52-week low stock price is 28.64, which is 15.9% below the current share price.
The average Viking Therapeutics stock price for the last 52 weeks is 58.15.
An investor who bought $1,000 worth of Viking Therapeutics stock at the IPO in 2015 would have $2,802 today, roughly 3 times their original investment - a 14.29% compound annual growth rate over 10 years.
The all-time high Viking Therapeutics stock closing price was 94.50 on February 28, 2024.
The Viking Therapeutics 52-week high stock price is 99.41, which is 191.8% above the current share price.
The Viking Therapeutics 52-week low stock price is 28.64, which is 15.9% below the current share price.
The average Viking Therapeutics stock price for the last 52 weeks is 58.15.